INTELLIA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
INTELLIA THERAPEUTICS, INC. (NTLA) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 1.64 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2026-06-30 was 119.40K shares, a 32.38% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2026-03-31 was 1.52M shares, a 0.53% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-12-31 was 273.95K shares, a 178.63% increase year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-09-30 was 116.35K shares, a 6.26% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2025 was 2.08M shares, a 44.87% increase from fiscal 2024.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2024 was 1.43M shares, a 111.75% increase from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2023 was 677.05K shares, a 358.48% increase from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for fiscal 2022 was 147.67K shares, a 23.35% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 119.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.64M shares 10-Q · filed 2026-08-06 | 1.91M shares derived: sum of 3 quarters · filed 2026-08-06 | 2.03M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 1.52M shares 10-Q · filed 2026-05-11 | 1.79M shares derived: sum of 2 quarters · filed 2026-05-11 | 1.91M shares derived: sum of 3 quarters · filed 2026-05-11 | 2.08M shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 273.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 390.30K shares derived: sum of 2 quarters · filed 2026-02-26 | 566.88K shares derived: sum of 3 quarters · filed 2026-02-26 | 2.08M shares 10-K · filed 2026-02-26 |
| 2025-09-30 | 116.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 292.93K shares derived: sum of 2 quarters · filed 2025-11-06 | 1.80M shares 10-Q · filed 2025-11-06 | 1.90M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 176.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.69M shares 10-Q · filed 2025-08-07 | 1.78M shares derived: sum of 3 quarters · filed 2025-08-07 | 1.91M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 1.51M shares 10-Q · filed 2025-05-08 | 1.61M shares derived: sum of 2 quarters · filed 2025-05-08 | 1.73M shares derived: sum of 3 quarters · filed 2025-05-08 | 1.93M shares derived: sum of 4 quarters · filed 2025-05-08 |
| 2024-12-31 | 98.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | 222.44K shares derived: sum of 2 quarters · filed 2025-02-27 | 418.13K shares derived: sum of 3 quarters · filed 2025-02-27 | 1.43M shares 10-K · filed 2025-02-27 |
| 2024-09-30 | 124.12K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 319.81K shares derived: sum of 2 quarters · filed 2024-11-07 | 1.34M shares 10-Q · filed 2024-11-07 | 1.41M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 195.69K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 1.21M shares 10-Q · filed 2024-08-08 | 1.29M shares derived: sum of 3 quarters · filed 2024-08-08 | 1.39M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 1.02M shares 10-Q · filed 2024-05-09 | 1.09M shares derived: sum of 2 quarters · filed 2024-05-09 | 1.20M shares derived: sum of 3 quarters · filed 2024-05-09 | 1.35M shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 79.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | 183.18K shares derived: sum of 2 quarters · filed 2024-02-22 | 335.03K shares derived: sum of 3 quarters · filed 2024-02-22 | 677.05K shares 10-K · filed 2024-02-22 |
| 2023-09-30 | 103.73K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 255.59K shares derived: sum of 2 quarters · filed 2023-11-09 | 597.61K shares 10-Q · filed 2023-11-09 | 653.44K shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 151.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 493.88K shares 10-Q · filed 2023-08-03 | 549.71K shares derived: sum of 3 quarters · filed 2023-08-03 | 550.37K shares derived: sum of 4 quarters · filed 2023-08-03 |
| 2023-03-31 | 342.02K shares 10-Q · filed 2023-05-04 | 397.86K shares derived: sum of 2 quarters · filed 2023-05-04 | 398.52K shares derived: sum of 3 quarters · filed 2023-05-04 | 435.03K shares derived: sum of 4 quarters · filed 2023-05-04 |
| 2022-12-31 | 55.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | 56.49K shares derived: sum of 2 quarters · filed 2023-02-23 | 93.01K shares derived: sum of 3 quarters · filed 2023-02-23 | 147.67K shares 10-K · filed 2023-02-23 |
| 2022-09-30 | 662.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 37.18K shares derived: sum of 2 quarters · filed 2022-11-03 | 91.84K shares 10-Q · filed 2022-11-03 | 160.61K shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 36.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 91.18K shares 10-Q · filed 2022-08-04 | 159.95K shares derived: sum of 3 quarters · filed 2022-08-04 | 184.66K shares derived: sum of 4 quarters · filed 2022-08-04 |
| 2022-03-31 | 54.67K shares 10-Q · filed 2022-05-05 | 123.44K shares derived: sum of 2 quarters · filed 2022-05-05 | 148.15K shares derived: sum of 3 quarters · filed 2022-05-05 | 174.38K shares derived: sum of 4 quarters · filed 2022-05-05 |
| 2021-12-31 | 68.77K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 93.48K shares derived: sum of 2 quarters · filed 2022-02-24 | 119.72K shares derived: sum of 3 quarters · filed 2022-02-24 | 119.72K shares 10-K · filed 2022-02-24 |
| 2021-09-30 | 24.71K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 50.95K shares derived: sum of 2 quarters · filed 2021-11-04 | 50.95K shares 10-Q · filed 2021-11-04 | |
| 2021-06-30 | 26.23K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 26.23K shares 10-Q · filed 2021-08-05 | ||
| 2021-03-31 | 0.00 shares 10-Q · filed 2022-05-05 | |||
| 2020-12-31 | 82.83K shares 10-K · filed 2021-02-26 | |||
| 2019-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 736.00 shares derived: sum of 2 quarters · filed 2020-02-27 | 7.32K shares derived: sum of 3 quarters · filed 2020-02-27 | 37.20K shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 736.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | 7.32K shares derived: sum of 2 quarters · filed 2019-10-31 | 37.20K shares 10-Q · filed 2019-10-31 | 70.54K shares derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | 6.58K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | 36.46K shares 10-Q · filed 2019-08-01 | 69.80K shares derived: sum of 3 quarters · filed 2019-08-01 | 149.60K shares derived: sum of 4 quarters · filed 2019-08-01 |
| 2019-03-31 | 29.88K shares 10-Q · filed 2019-05-02 | 63.22K shares derived: sum of 2 quarters · filed 2019-05-02 | 143.02K shares derived: sum of 3 quarters · filed 2019-05-02 | 291.41K shares derived: sum of 4 quarters · filed 2019-05-02 |
| 2018-12-31 | 33.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | 113.14K shares derived: sum of 2 quarters · filed 2019-02-27 | 261.53K shares derived: sum of 3 quarters · filed 2019-02-27 | 411.37K shares 10-K · filed 2019-02-27 |
| 2018-09-30 | 79.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | 228.19K shares derived: sum of 2 quarters · filed 2018-10-31 | 378.03K shares 10-Q · filed 2018-10-31 | 610.84K shares derived: sum of 4 quarters · filed 2018-10-31 |
| 2018-06-30 | 148.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | 298.23K shares 10-Q · filed 2018-08-01 | 531.04K shares derived: sum of 3 quarters · filed 2018-08-01 | 715.60K shares derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | 149.85K shares 10-Q · filed 2018-05-01 | 382.66K shares derived: sum of 2 quarters · filed 2018-05-01 | 567.21K shares derived: sum of 3 quarters · filed 2018-05-01 | 754.50K shares derived: sum of 4 quarters · filed 2018-05-01 |
| 2017-12-31 | 232.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | 417.37K shares derived: sum of 2 quarters · filed 2018-03-14 | 604.65K shares derived: sum of 3 quarters · filed 2018-03-14 | 791.57K shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 184.56K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | 371.84K shares derived: sum of 2 quarters · filed 2017-10-31 | 558.76K shares 10-Q · filed 2017-10-31 | 747.66K shares derived: sum of 4 quarters · filed 2017-10-31 |
| 2017-06-30 | 187.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | 374.20K shares 10-Q · filed 2017-08-01 | 563.11K shares derived: sum of 3 quarters · filed 2017-08-01 | 776.93K shares derived: sum of 4 quarters · filed 2017-08-01 |
| 2017-03-31 | 186.92K shares 10-Q · filed 2017-05-02 | 375.82K shares derived: sum of 2 quarters · filed 2017-05-02 | 589.64K shares derived: sum of 3 quarters · filed 2017-05-02 | |
| 2016-12-31 | 188.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | 402.72K shares derived: sum of 2 quarters · filed 2017-03-14 | 864.23K shares 10-K · filed 2017-03-14 | |
| 2016-09-30 | 213.82K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | 675.33K shares 10-Q · filed 2016-11-01 | ||
| 2016-06-30 | 461.51K shares 10-Q · filed 2016-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |